Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-023081

President and CEO sold 5,922 shares at an average $0.55 ($3,248)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-18 Sale : show line 1 in the form 10b5-1 −2,865 $0.60 $1,719 636,801 D
2023-08-21 Sale : show line 2 in the form 10b5-1 −3,057 $0.50 $1,529 633,744 D
Open-market sales · 5,922 sh · avg $0.55 · $3,248
Loading xslF345X05/form4.xml…